HomeHEPA • NASDAQ
add
Hepion Pharmaceuticals Inc
Previous close
$0.67
Day range
$0.62 - $0.70
Year range
$0.55 - $4.37
Market cap
4.42M USD
Avg Volume
64.92K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 4.46M | -58.20% |
Net income | -4.87M | 53.78% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.98M | 62.58% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.50M | -92.24% |
Total assets | 3.72M | -85.14% |
Total liabilities | 4.12M | -53.40% |
Total equity | -406.68K | — |
Shares outstanding | 6.96M | — |
Price to book | -2.23 | — |
Return on assets | -229.21% | — |
Return on capital | -402.88% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -4.87M | 53.78% |
Cash from operations | -2.52M | 77.59% |
Cash from investing | -600.00K | -23,337.80% |
Cash from financing | 2.50M | — |
Net change in cash | -617.94K | 94.50% |
Free cash flow | -1.60M | 78.49% |
About
Founded
2013
Website
Employees
22